These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3488591)

  • 1. Interferon therapy of lymphoproliferative disorders.
    Foon KA
    Semin Hematol; 1986 Jul; 23(3 Suppl 1):10-3. PubMed ID: 3488591
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interferon-alpha therapy for hairy cell leukemia and lymphoproliferative disorders simulating hairy cell leukemia (hairy cell leukemia variant): a cooperative group study in Japan].
    Machii T; Kitani T; Kimura K; Maekawa I; Matsuzaki M; Mikuni C; Niikawa K; Igarashi T; Abe T; Miura Y
    Rinsho Ketsueki; 1988 Nov; 29(11):2029-36. PubMed ID: 3070073
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant alpha interferons 1986: a review.
    Lindquist DL; Burns CP
    Iowa Med; 1987 Jan; 77(1):32, 34, 36. PubMed ID: 3818250
    [No Abstract]   [Full Text] [Related]  

  • 4. INTRON A (interferon alfa-2b): clinical overview.
    Spiegel RJ
    Cancer Treat Rev; 1985 Dec; 12 Suppl B():5-16. PubMed ID: 3914355
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic leukemias: oncogenes, chromosomes, and advances in therapy.
    Champlin R; Gale RP; Foon KA; Golde DW
    Ann Intern Med; 1986 May; 104(5):671-88. PubMed ID: 3008618
    [No Abstract]   [Full Text] [Related]  

  • 6. Interferon-alpha: current status and future promise.
    Bonnem EM; Spiegel RJ
    J Biol Response Mod; 1984 Dec; 3(6):580-98. PubMed ID: 6392483
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of a multicenter study of the efficacy of recombinant alpha-2c interferon in hairy cell leukemia].
    Werter MJ; Bogman MJ; Janssen JT; de Pauw BE; Haanen CA
    Ned Tijdschr Geneeskd; 1987 Nov; 131(46):2081-5. PubMed ID: 3683637
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interferon-alpha in the treatment of hematologic neoplasms].
    Aulitzky W; Gastl G; Tilg H; Troppmair J; Leiter E; Geissler D; Flener R; Huber C
    Wien Med Wochenschr; 1986 Apr; 136(7-8):172-81. PubMed ID: 3524022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-alpha-2C in the treatment of advanced hairy cell leukaemia. Results of a phase II trial.
    Huber C; Flener R; Gastl G
    Oncology; 1985; 42 Suppl 1():7-9. PubMed ID: 4080300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-2 interferon therapy for cutaneous T cell lymphoma.
    Tulli A
    J Am Acad Dermatol; 1989 Apr; 20(4):686-7. PubMed ID: 2785538
    [No Abstract]   [Full Text] [Related]  

  • 11. Alpha interferons in the treatment of hairy cell leukemia.
    Quesada JR
    Immunobiology; 1986 Sep; 172(3-5):250-4. PubMed ID: 3804367
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alpha interferon and lymphoid hemopathies].
    Flandrin G
    Ann Med Interne (Paris); 1989; 139(8):530-3. PubMed ID: 2729810
    [No Abstract]   [Full Text] [Related]  

  • 13. The UCLA experience with type I interferons in hairy cell leukemia.
    Glaspy JA; Jacobs AD; Golde DW
    Leukemia; 1987 Apr; 1(4):323-6. PubMed ID: 3312839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experience in treating patients with hairy-cell leukemia with a Soviet genetically engineered interferon].
    Lepkov SV; Kruglova GV; Volkova MA; Demina EA
    Ter Arkh; 1989; 61(7):133-6. PubMed ID: 2588131
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship of the clinical response and binding of recombinant interferon alpha in patients with lymphoproliferative diseases.
    Faltynek CR; Princler GL; Rossio JL; Ruscetti FW; Maluish AE; Abrams PG; Foon KA
    Blood; 1986 Apr; 67(4):1077-82. PubMed ID: 2937469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of hematologic diseases with alpha interferon].
    Castaigne S
    Bull Cancer; 1988; 75(9):859-62. PubMed ID: 3207895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha interferon treatment of low-grade B-cell non-Hodgkin's lymphomas, cutaneous T-cell lymphomas, and chronic lymphocytic leukemia.
    Foon KA; Roth MS; Bunn PA
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):35-42. PubMed ID: 3532334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of bone marrow changes during the treatment of hairy cell leukemia with interferon alpha.
    Flandrin G; Sigaux F; Castaigne S; Degos L
    Cancer Treat Rev; 1985 Dec; 12 Suppl B():17-22. PubMed ID: 3833326
    [No Abstract]   [Full Text] [Related]  

  • 19. [Management of hairy cell leukemia with human leukocyte interferons].
    Ikkala E; Ala-Harja K; Almqvist A; Hallman H; Honkanen T; Pelliniemi TT; Timonen T
    Duodecim; 1987; 103(16):977-80. PubMed ID: 3454328
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies in patients with hairy-cell leukemia receiving alpha-2b interferon.
    Jacobs SL; Kelsey DK
    N Engl J Med; 1986 Nov; 315(22):1418. PubMed ID: 3773970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.